Application 216403
- Type
- NDA
- Sponsor
- TRAVERE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FILSPARI | SPARSENTAN | TABLET;ORAL | 200MG | Yes | No |
| 002 | FILSPARI | SPARSENTAN | TABLET;ORAL | 400MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N216403-001 | FILSPARI | SPARSENTAN | 200MG | TABLET / ORAL | RLD | 2023-02-17 | |
| N216403-002 | FILSPARI | SPARSENTAN | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N216403-001 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | |
| N216403-001 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | |
| N216403-001 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | |
| N216403-001 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | |
| N216403-001 | 12714697 | 2037-10-13 | U-3993 | 2026-09-22 | |
| N216403-002 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | |
| N216403-002 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | |
| N216403-002 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | |
| N216403-002 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | |
| N216403-002 | 12714697 | 2037-10-13 | U-3993 | 2026-09-22 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N216403-001 | NCE | 2028-02-17 |
| N216403-001 | I-989 | 2029-04-13 |
| N216403-001 | ODE-389 | 2030-02-17 |
| N216403-001 | ODE-493 | 2031-09-05 |
| N216403-002 | NCE | 2028-02-17 |
| N216403-002 | I-989 | 2029-04-13 |
| N216403-002 | ODE-389 | 2030-02-17 |
| N216403-002 | ODE-493 | 2031-09-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N216403-001 | FILSPARI | 200MG | TABLET / ORAL | RLD | 2023-02-17 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N216403-002 | FILSPARI | 400MG | TABLET / ORAL | RLD, RS | 2023-02-17 | 1c564ffb4f44… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | 12714697 | 2037-10-13 | U-3993 | 2026-09-22 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | 12714697 | 2037-10-13 | U-3993 | 2026-09-22 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | 12714697 | 2037-10-13 | U-3993 | 2026-09-22 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | 12714697 | 2037-10-13 | U-3993 | 2026-09-22 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-001 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-001 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-001 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-001 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-002 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-002 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-002 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N216403-002 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-001 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-001 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-001 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-001 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-002 | 9662312 | 2030-03-29 | U-4495 | 2026-05-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-002 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-002 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216403-002 | 9993461 | 2030-03-29 | U-4495 | 2023-03-14 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-001 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-001 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-002 | 9993461 | 2030-03-29 | U-3269 | 2023-03-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-002 | 9993461 | 2030-03-29 | U-3993 | 2023-03-14 | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | NCE | 2028-02-17 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | I-989 | 2029-04-13 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | ODE-389 | 2030-02-17 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216403-001 | ODE-493 | 2031-09-05 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | NCE | 2028-02-17 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | I-989 | 2029-04-13 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | ODE-389 | 2030-02-17 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216403-002 | ODE-493 | 2031-09-05 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | NCE | 2028-02-17 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | I-989 | 2029-04-13 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | ODE-389 | 2030-02-17 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216403-001 | ODE-493 | 2031-09-05 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | NCE | 2028-02-17 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | I-989 | 2029-04-13 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | ODE-389 | 2030-02-17 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216403-002 | ODE-493 | 2031-09-05 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N216403-001 | NCE | 2028-02-17 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216403-001 | I-989 | 2029-04-13 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216403-001 | ODE-389 | 2030-02-17 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216403-001 | ODE-493 | 2031-09-05 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216403-002 | NCE | 2028-02-17 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216403-002 | I-989 | 2029-04-13 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216403-002 | ODE-389 | 2030-02-17 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216403-002 | ODE-493 | 2031-09-05 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N216403-001 | NCE | 2028-02-17 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216403-001 | I-989 | 2029-04-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216403-001 | ODE-389 | 2030-02-17 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216403-001 | ODE-493 | 2031-09-05 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216403-002 | NCE | 2028-02-17 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216403-002 | I-989 | 2029-04-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216403-002 | ODE-389 | 2030-02-17 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216403-002 | ODE-493 | 2031-09-05 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-001 | NCE | 2028-02-17 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-001 | ODE-389 | 2030-02-17 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-001 | ODE-493 | 2031-09-05 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-002 | NCE | 2028-02-17 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-002 | ODE-389 | 2030-02-17 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216403-002 | ODE-493 | 2031-09-05 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216403-001 | NCE | 2028-02-17 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216403-001 | ODE-389 | 2030-02-17 | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FILSPARI | SPARSENTAN | Travere Therapeutics, Inc. | d7354af1-f304-f4d9-e053-2995a90ab219 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 216403 NDA216403 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85689 | SUPPL | 2026-04-15 |
| 85686 | SUPPL | 2026-04-15 |
| 85683 | SUPPL | 2026-04-15 |
| 85117 | SUPPL | 2026-02-24 |
| 83228 | SUPPL | 2025-08-29 |
| 83223 | SUPPL | 2025-08-28 |
| 83222 | SUPPL | 2025-08-28 |
| 79558 | SUPPL | 2024-09-06 |
| 79545 | SUPPL | 2024-09-06 |
| 76361 | ORIG | 2023-11-06 |
| 75848 | SUPPL | 2023-10-19 |
| 75285 | ORIG | 2023-08-14 |
| 73567 | ORIG | 2023-02-21 |
| 73566 | ORIG | 2023-02-21 |
| 73560 | ORIG | 2023-02-17 |